GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Bharat Parenterals Ltd

Bharat Parenterals Ltd schedules Oct 29 board meeting for Q2 FY27 results

BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 24 Oct 2026, 10:17 AM IST  ·  BSE ID: fffcadea-bb15-44ee-a1f2-3e8f33ec719d
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's directors will meet soon to finalize and release its latest financial performance report for the past three and six months.
🤖 AI Summary
  • Board meeting scheduled for October 29, 2026, to approve financial results.
  • Results to cover the quarter and half-year ended September 30, 2026.
  • Unaudited standalone and consolidated financials will be reviewed.
  • Trading window for designated persons closed from October 1, 2026.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time.
👤
Who Is Affected
All shareholders are potentially affected by the upcoming financial results announcement.
🔍
Management Signal
Management is adhering to regulatory timelines for financial result disclosure.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
October 29, 2026 board meeting for financial results approval.
Release of unaudited Q2 FY27 standalone financial results.
Release of unaudited Q2 FY27 consolidated financial results.
LOW RISK This filing is a standard procedural notification of an upcoming board meeting.
💡 Investor Takeaway
Bharat Parenterals Ltd will announce its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, on October 29, 2026.
❓ Frequently Asked Questions
When is Bharat Parenterals Ltd's board meeting scheduled?
Bharat Parenterals Ltd's board meeting is scheduled for October 29, 2026.
What will be discussed at Bharat Parenterals Ltd's board meeting on October 29, 2026?
The board will consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026.
When is the trading window closed for Bharat Parenterals Ltd?
The trading window for designated persons is closed from October 1, 2026, until 48 hours after the declaration of the financial results.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.